APA引文

Xia, J., Li, Z., & Xu, K. (2023, June). Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: Latest updates from 2022 ASH Annual Meeting. Journal of Hematology & Oncology.

Chicago Style (17th ed.) Citation

Xia, Jieyun, Zhenyu Li, and Kailin Xu. "Immunotherapies Targeting GPRC5D in Relapsed or Refractory Multiple Myeloma: Latest Updates from 2022 ASH Annual Meeting." Journal of Hematology & Oncology Jun. 2023.

MLA引文

Xia, Jieyun, et al. "Immunotherapies Targeting GPRC5D in Relapsed or Refractory Multiple Myeloma: Latest Updates from 2022 ASH Annual Meeting." Journal of Hematology & Oncology, Jun. 2023.